This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Gary White: Innovator in Fusion Proteins
Introduction
Gary White is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins that target specific signaling pathways.
Latest Patents
Gary White holds a patent for "Fusion proteins and methods for inhibiting IL-17 pathways." This patent describes fusion proteins that include an IL-17 receptor with a multimerization domain, or an IL-23 receptor and a multimerization domain. Additionally, it covers recombinant viral vectors encoding such fusions. These fusion proteins and vectors can be utilized in methods for modulating the IL-17 and IL-23 signaling pathways. They are particularly relevant for treating or preventing diseases mediated by interleukin-17 and interleukin-23, such as immune-related and inflammatory diseases. Gary White has 1 patent to his name.
Career Highlights
Gary White is associated with Genzyme Corporation, where he has been instrumental in advancing research and development in his field. His work has contributed to innovative solutions in biotechnology.
Collaborations
Gary White collaborates with Abraham Scaria, enhancing the research efforts within their organization.
Conclusion
Gary White's contributions to the field of fusion proteins and his innovative patent demonstrate his commitment to advancing medical science. His work continues to have a significant impact on the treatment of immune-related and inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile